NEW YORK , Oct. 3, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Ardelyx, Inc. ("Ardelyx" or the "Company") (NASDAQ: ARDX ) and certain officers.
The class action, filed in the United States District Court for the District of Massachusetts , and docketed under 24-cv-12119, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Ardelyx securities between October 31, 2023 and July 1, 2024 , both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") and Rule 10b -5 promulgated thereunder, against the Company and certain of its top officers. If you are a shareholder who purchased or otherwise acquired Ardelyx securities during the Class Period, you have until October 15, 2024 to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.
pomerantzlaw.com . To discuss this action, contact Danielle Peyton at [email protected] or 646-581-9980 (or 888.
4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
[Click here for information about joining the class action] Ardelyx is a biotechnology company focused on developing and comm.